Phillip J. Brown

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays

Kevin R. Bewley, Naomi S. Coombes, Luc Gagnon et al. · Nature Protocols · 2021 · 317 citations · Full text

Virus Neutralization Assays, Viral Diagnostics, Viral Pathogenesis +6

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

Kathryn A. Ryan, Kevin R. Bewley, Susan Fotheringham et al. · Nature Communications · 2021 · 185 citations · Full text

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19

Francisco J. Salguero, Andrew White, Gillian S. Slack et al. · Nature Communications · 2021 · 160 citations · Full text

Virus Epidemiology, Viral Diagnostics, Viral Pathogenesis +17